These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4587671)

  • 21. Studies in glycogen storage disease type 3: kinetics of amylo-1,6-glucosidase in human erythrocytes.
    Garatun-Tjeldstö E; Garatun-Tjeldstö O
    Scand J Clin Lab Invest; 1971 May; 27(3):269-72. PubMed ID: 5281102
    [No Abstract]   [Full Text] [Related]  

  • 22. Biochemical genetics of the Lapland dog model of glycogen storage disease type II (acid alpha-glucosidase deficiency).
    Walvoort HC; Slee RG; Sluis KJ; Koster JF; Reuser AJ
    Am J Med Genet; 1984 Nov; 19(3):589-98. PubMed ID: 6391168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a homozygous D645E mutation of the acid alpha-glucosidase gene and glycogen deposition in tissues in a second-trimester fetus with infantile glycogen storage disease type II.
    Chen CP; Lin SP; Tzen CY; Tsai FJ; Hwu WL; Wang W
    Prenat Diagn; 2004 Mar; 24(3):231-2. PubMed ID: 15057961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of periodate oxidation on activity of acid alpha-glucosidase from human liver].
    Mikhaĭlov VI; Belen'kiĭ DM
    Vopr Med Khim; 1982; 28(3):48-50. PubMed ID: 7048734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lysosomes in the pathogeny of storage diseases.
    Hers HG
    Biochimie; 1972; 54(5):753-7. PubMed ID: 4265927
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycogen storage disease. Studies related to the mechanism of glycogenosome formation.
    Iwamasa T; Ninomiya N; Fukuda S; Hamada T; Hirashima M; Osame M
    Pathol Res Pract; 1983 Mar; 176(2-4):236-52. PubMed ID: 6304667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations of glycogen level and alpha-glucosidase activity in human malignant epithelial cell lines in culture.
    Paris H; Rousset M; Terrain B; Chevalier G; Zweibaum A; Murat JC
    Int J Biochem; 1982; 14(2):141-5. PubMed ID: 6802687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An electron microscopic and biochemical study of the effects of glucagon on newborn rat hepatocytes.
    Kotoulas OB
    Bull Assoc Anat (Nancy); 1984 Jun; 68(201):189-97. PubMed ID: 6399004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acid maltase deficiency myopathy infantile and adult forms (author's transl)].
    Saenz Lope E; Cocero Oviedo E; Ricoy Campo JR; Benlloch T
    Arch Neurobiol (Madr); 1981; 44(1):49-62. PubMed ID: 6784694
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydrolases in the epithelium of the small intestine of the guinea-pig during prenatal development (author's transl)].
    Strauss E; Gossrau R
    Z Mikrosk Anat Forsch; 1981; 95(5):721-65. PubMed ID: 7331397
    [No Abstract]   [Full Text] [Related]  

  • 31. [Distribution of glycogen-filled lysosomes in the kidney in type II glycogenosis (author's transl)].
    von Bassewitz DB
    Verh Dtsch Ges Pathol; 1976; ():252-4. PubMed ID: 1071522
    [No Abstract]   [Full Text] [Related]  

  • 32. A fluorometric assay of alpha-glucosidase and its application in the study of Pompe's disease.
    Salafsky IS; Nadler HL
    J Lab Clin Med; 1973 Mar; 81(3):450-4. PubMed ID: 4265648
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glycogen storage diseases].
    Field JB
    Acta Diabetol Lat; 1969; 6(1):1-19. PubMed ID: 5256103
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acid maltase deficiency in 2 adolescent siblings].
    Gracia P; Benlloch T; de la Fuente G; Durántez A; Espanña P; Cánovas A; Illera ER
    Med Clin (Barc); 1982 Sep; 79(5):227-31. PubMed ID: 6755088
    [No Abstract]   [Full Text] [Related]  

  • 35. Administration of a mixture of fungal glucosidases to a patient with type II glycogenosis (Pompe's disease).
    Lauer RM; Mascarinas T; Racela AS; Diehl AM; Brown BI
    Pediatrics; 1968 Oct; 42(4):672-6. PubMed ID: 5245517
    [No Abstract]   [Full Text] [Related]  

  • 36. Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers.
    Raben N; Fukuda T; Gilbert AL; de Jong D; Thurberg BL; Mattaliano RJ; Meikle P; Hopwood JJ; Nagashima K; Nagaraju K; Plotz PH
    Mol Ther; 2005 Jan; 11(1):48-56. PubMed ID: 15585405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycogen metabolism and glycogen-storage diseases.
    Huijing F
    Physiol Rev; 1975 Oct; 55(4):609-58. PubMed ID: 1103168
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycogen storage disease.
    Br Med J; 1969 Apr; 2(5649):68. PubMed ID: 5251661
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzyme induction in a case of glycogen storage disease.
    Moses SW; Levin S; Chayoth R; Steinitz K
    Pediatrics; 1966 Jul; 38(1):111-21. PubMed ID: 5220063
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple muscles in the AMD quail can be "cross-corrected" of pathologic glycogen accumulation after intravenous injection of an [E1-, polymerase-] adenovirus vector encoding human acid-alpha-glucosidase.
    McVie-Wylie AJ; Ding EY; Lawson T; Serra D; Migone FK; Pressley D; Mizutani M; Kikuchi T; Chen YT; Amalfitano A
    J Gene Med; 2003 May; 5(5):399-406. PubMed ID: 12731088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.